In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases DOI Creative Commons
Yuan Li, Fan Tong, Yufan Wang

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2024, Номер 14(9), С. 4102 - 4117

Опубликована: Июнь 12, 2024

Tumor vaccine, a promising modality of tumor immunotherapy, needs to go through the process antigen generation and loading, drainage lymph nodes (LNs), internalization by dendritic cells (DCs), DC maturation, cross-presentation activate T-cells. However, vaccines are often unable satisfy all steps, leading limitation their application efficacy. Herein, based on smart nanogel system, an

Язык: Английский

Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell DOI Creative Commons
Lu Diao, Mi Liu

Advanced Science, Год журнала: 2023, Номер 10(22)

Опубликована: Май 31, 2023

Abstract Cancer immunotherapies have improved human health, and one among the important technologies for cancer immunotherapy is vaccine. Antigens are most components in vaccines. Generally, antigens vaccines can be divided into two categories: pre‐defined unidentified antigens. Although, loaded with predefined commonly used, vaccine mixed antigens, especially whole cells or cell lysates, a very promising approach, such obviate some limitations Their advantages include, but not limited to, inclusion of pan‐spectra (all kinds of) inducing pan‐clones specific T cells, overcoming heterogeneity cells. In this review, recent advances based on whole‐tumor either summarized. terms focus applying water‐soluble lysates as Recently, utilizing has become feasible. Considering that pre‐determined antigen‐based (mainly peptide‐based mRNA‐based) various limitations, developing alternative.

Язык: Английский

Процитировано

69

Structural Motifs in Covalent Organic Frameworks for Photocatalysis DOI

Liyang Qin,

Chengdi Ma,

Jian Zhang

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер unknown

Опубликована: Март 10, 2024

Abstract Covalent organic frameworks (COFs) attract significant attention due to their ordered, crystalline, porous, metal‐free, and predictable structures. These unique characteristics offer great opportunities for the diffusion transmission of photogenerated charges during photocatalysis. Currently, a considerable number COFs are used as metal‐free semiconductor photocatalysts. This review aims understand relationships between structure photocatalysis performance provides in‐depth insight into synthetic strategy improve performance. Subsequently, focuses on structural motif in sustainable photocatalytic hydrogen evolution, carbon dioxide reduction, peroxide generation, compound transformations. Last, conjunction with progress achieved challenges yet be overcome, candid discussion is undertaken regarding field COF photocatalysis, accompanied by presentation potential research avenues future directions. seeks provide readers comprehensive understanding pivotal role robust guidance innovative utilization

Язык: Английский

Процитировано

61

Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications DOI
Xianbo Wu, Yuqing Li, Mei Wen

и другие.

Chemical Society Reviews, Год журнала: 2024, Номер 53(5), С. 2643 - 2692

Опубликована: Янв. 1, 2024

This review discusses the structures and engineering strategies of nanocatalysts, highlighting their underlying mechanisms applications in cancer immunotherapy.

Язык: Английский

Процитировано

36

Biomimetic cascade intelligent paper chip sensor based on bimetallic porphyrin-based covalent organic framework with triple-enzyme mimetic activities DOI

Yujiao Bai,

Wenqing Gao,

Jinhao Wei

и другие.

Chemical Engineering Journal, Год журнала: 2024, Номер 490, С. 151628 - 151628

Опубликована: Апрель 25, 2024

Язык: Английский

Процитировано

21

Metal‐Phenolic Nanocloaks on Cancer Cells Potentiate STING Pathway Activation for Synergistic Cancer Immunotherapy DOI

Xianglian He,

Guidong Gong, Mei Chen

и другие.

Angewandte Chemie International Edition, Год журнала: 2024, Номер 63(12)

Опубликована: Фев. 2, 2024

Abstract Due to the presence of natural neoantigens, autologous tumor cells hold great promise as personalized therapeutic vaccines. Yet cell vaccines require multi‐step production that frequently leads loss immunoreactive antigens, causing insufficient immune activation and significantly hampering their clinical applications. Herein, we introduce a novel whole‐cell cancer vaccine by cloaking with lipopolysaccharide‐decorated manganese(II)‐phenolic networks (MnTA nanocloaks) evoke tumor‐specific response for highly efficacious synergistic immunotherapy. The polyphenols coordinate Mn 2+ immediately adhere surface individual cells, thereby forming nanocloak encapsulating neoantigens. Subsequent decoration lipopolysaccharide induces internalization dendritic where ions are released in cytosol, further facilitating stimulator interferon genes (STING) pathway. Highly effective suppression was observed combining nanocloaked treatment anti‐programmed death ligand 1 (anti‐PD‐L1) antibodies‐mediated checkpoint blockade therapy. Our work demonstrates universal yet simple strategy engineer cell‐based nanobiohybrid system enhanced

Язык: Английский

Процитировано

19

Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy DOI Creative Commons
Liang Zhang, Boxin Zhang, Mengjie Zhang

и другие.

Nature Communications, Год журнала: 2025, Номер 16(1)

Опубликована: Янв. 2, 2025

The discovery of tertiary lymphoid structures (TLS) within tumor tissues provides a promising avenue to promote the efficacy cancer immunotherapy. Yet, lack effective strategies induce TLS formation poses substantial obstacle. Thus, exploration potential inducers for is great interest but remains challenging. Here, inspired by mechanism artificially cultivated pearls, covalent organic framework (COF) employed formation. Single-cell sequencing analysis reveals that this achieved promotion cytokine hypersecretion, which facilitates maturation, proliferation, and migration T B cells, critical triggering Furthermore, COF-mediated phototherapy in inducing validated both MC38 4MOSC1 female models. Notably, strong synergistic effect between αCTLA-4 observed, resulting eradication primary distant tumors, while also inhibiting recurrence. boosting immunotherapy, it challenging develop authors report able trigger

Язык: Английский

Процитировано

2

Hypoxia‐Responsive Covalent Organic Framework Nanoplatform for Breast‐Cancer‐Targeted Cocktail Immunotherapy via Triple Therapeutic Switch Mechanisms DOI Open Access

Guoqin Huang,

Lianying Zhang,

Jiahao Feng

и другие.

Small, Год журнала: 2025, Номер unknown

Опубликована: Янв. 10, 2025

Abstract Covalent organic frameworks (COFs), known for their exceptional in situ encapsulation and precise release capabilities, are emerging as pioneering drug delivery systems. This study introduces a hypoxia‐responsive COF designed to encapsulate the chemotherapy gambogic acid (GA) situ. Bimetallic gold‐palladium islands were grown on UiO‐66‐NH 2 (UiO) form UiO@Au‐Pd (UAPi), which encapsulated with GA through membrane formation, resulting core‐shell structure (UAPiGC). Further modification hyaluronic (HA) created @GA‐COF@HA (UAPiGCH) enhanced tumor targeting. In hypoxic microenvironment, collapses, releasing UAPi, initiating triple therapeutic response: nanozyme‐catalyzed therapy, near‐infrared II (NIR‐II) mild photothermal therapy (mild‐PTT), chemotherapy. UAPi exhibits catalase (CAT)‐like peroxidase (POD)‐like activities, generating oxygen alleviate hypoxia reactive species (ROS) destruction. acts chemotherapeutic agent inhibits heat shock protein 90 (HSP90), enhancing sensitivity. vitro vivo studies confirm UAPiGCH’s ability induce pyroptosis, stimulate dendritic cell maturation, boost T infiltration, demonstrating its potential nanoplatform. strategy integrates multiple therapies into system, offering promising applications cancer treatment.

Язык: Английский

Процитировано

2

Transforming Intratumor Bacteria into Immunopotentiators to Reverse Cold Tumors for Enhanced Immuno-chemodynamic Therapy of Triple-Negative Breast Cancer DOI

Xuemeng Liu,

Mengyu Sun, Fang Pu

и другие.

Journal of the American Chemical Society, Год журнала: 2023, Номер 145(48), С. 26296 - 26307

Опубликована: Ноя. 21, 2023

Immunotherapy of triple-negative breast cancer (TNBC) has an unsatisfactory therapeutic outcome due to immunologically "cold" microenvironment. Fusobacterium nucleatum (F. nucleatum) was found be colonized in tumors and responsible for the immunosuppressive tumor microenvironment metastasis. Herein, we constructed a bacteria-derived outer membrane vesicle (OMV)-coated nanoplatform that precisely targeted tissues dual killing F. cells, thus transforming intratumor bacteria into immunopotentiators immunotherapy TNBC. The as-prepared nanoparticles efficiently induced immunogenic cell death through Fenton-like reaction, resulting enhanced immunogenicity. Meanwhile, intratumoral killed by metronidazole, release pathogen-associated molecular patterns (PAMPs). PAMPs cooperated with OMVs further facilitated maturation dendritic cells subsequent T-cell infiltration. As result, "kill two birds one stone" strategy warmed up cold environment, maximized antitumor immune response, achieved efficient therapy TNBC as well metastasis prevention. Overall, this based on microecology distinction normal tissue microbiome-induced reversal provides new insight precise

Язык: Английский

Процитировано

41

Target‐Specific Bioorthogonal Reactions for Precise Biomedical Applications DOI Open Access
Zhengwei Liu, Mengyu Sun, Wenting Zhang

и другие.

Angewandte Chemie International Edition, Год журнала: 2023, Номер 62(49)

Опубликована: Авг. 7, 2023

Abstract Bioorthogonal chemistry is a promising toolbox for dissecting biological processes in the native environment. Recently, bioorthogonal reactions have attracted considerable attention medical field treating diseases, since this approach may lead to improved drug efficacy and reduced side effects via situ synthesis. For precise biomedical applications, it prerequisite that should occur right locations on appropriate therapeutic targets. In minireview, we highlight design development of targeted treatment. First, compile recent strategies achieving target‐specific reactions. Further, emphasize their application treatment different Finally, perspective provided challenges future directions emerging safe, efficient, translatable disease

Язык: Английский

Процитировано

29

A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors DOI
Bihan Wu,

Juan Liang,

Xuejiao Yang

и другие.

Journal of the American Chemical Society, Год журнала: 2024, Номер 146(12), С. 8585 - 8597

Опубликована: Март 13, 2024

Adjuvant treatment after surgical resection usually plays an important role in delaying disease recurrence. Immunotherapy displays encouraging results increasing patients' chances of staying cancer-free surgery, as reported by recent clinical trials. However, the outcomes current immunotherapy need to be improved due limited responses, patient heterogeneity, nontargeted distribution, and immune-related adverse effects. This work describes a programmable hydrogel adjuvant for personalized resection. By filling cavity, this system aims address secretion granzyme B (GrB) during improve low responses typically observed, while minimizing side The TLR7/8 agonist imidazoquinoline (IMDQ) is linked self-assembling peptide backbone through GrB-responsive linkage. Its release could enhance activation function immune cells, which will lead increased GrB effectiveness together. recruits initiates dendritic cell maturation, induces M1 polarized macrophages reverse immunosuppressive tumor microenvironment situ. In multiple murine models, suppresses growth, increases animal survival long-term immunological memory, protects mice against rechallenge, leading effective prophylactic therapeutic responses. provides potential chemical strategy overcome limitations associated with immunotherapy.

Язык: Английский

Процитировано

15